Screening for Conditions by Electronic Nose Technology (SCENT III) (Clinical Trial Not Allowed)
Forecasted
This grant funds the development of noninvasive electronic nose technology to detect disease biomarkers from human skin for real-time diagnosis and monitoring, aiming to improve and complement traditional diagnostic methods.
This grant is no longer accepting proposals
National Institutes of Health has archived this opportunity.
Funder: National Institutes of Health
Due Dates (Anticipated): June 2027 (Full application deadline, projected) | June 2026 (Application deadline, projected)
Funding Amounts: Not specified; award size and number of awards to be determined in future NOFO.
Summary: Supports development of noninvasive electronic nose technologies for disease diagnosis and monitoring using volatile organic compound (VOC) biosensing.
Key Information: This is a forecasted opportunity; all deadlines and details are projected and subject to change.
Description
This forecasted funding opportunity from the National Institutes of Health (NIH) seeks proposals to develop advanced electronic nose (e-nose) technologies that mimic the human olfactory system. The goal is to create robust, noninvasive diagnostic platforms capable of detecting volatile organic compound (VOC) signatures associated with a wide range of diseases. The envisioned tools will integrate improved sensing, detection, and analytical capabilities for real-time, in situ disease diagnosis and monitoring—potentially complementing or replacing traditional, invasive, and costly diagnostic procedures. This initiative aligns with the National Center for Advancing Translational Sciences (NCATS) vision to accelerate the translation of biomedical innovations into practical health solutions.
